Morningsun
Research payments
$20,500,150
Through program year 2024, $20,500,150 in research payments was reported against Morningsun, across 4,381 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG; Chugai Pharmaceutical Co., Ltd.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $11,023,340 | 3,716 |
| 2023 | Research | $8,887,242 | 650 |
| 2022 | Research | $589,568 | 15 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Burke Aurora, CO Named on 934 payments
- Jamal Misleh Garnet Valley, PA Named on 425 payments
- Jeff Sharman Eugene, OR Named on 403 payments
- Mitul Gandhi Chicago, IL Named on 347 payments
- Jason Melear Austin, TX Named on 224 payments
- Praveen Tumula Amarillo, TX Named on 138 payments
- Mihir Raval Albany, NY Named on 119 payments
- Richard Zuniga Farmington Hills, MI Named on 107 payments
- Houston Holmes Dallas, TX Named on 105 payments
- Vijay Patel Kansas City, KS Named on 96 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.